The Swedish CArdioPulmonary bioImage Study – SCAPIS – is a nationwide, open-access, population-based cohort for the study of cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD).

The aim is to predict and prevent cardiovascular and pulmonary disease. A total of 30,154 men and women in Sweden, from 50 to 64 years old, have been recruited and investigated with detailed imaging and functional analyses of the cardiovascular and pulmonary systems. The first public release of data was on March 17, 2021. All researchers based in Sweden, or international researchers in collaboration with an applicant based in Sweden, are welcome to apply for data.

The novelty and significant contribution of SCAPIS is that it combines size with extensive phenotyping. The aim of SCAPIS is to predict and prevent CVD and CPD. The goal is to further develop individualized treatment and improve health care by building this research resource.

SCAPIS is a unique study made possible through a collaborative effort between six Swedish universities (Uppsala University, Umeå University, Linköping University, Lund University, University of Gothenburg and Karolinska Institutet) and university hospitals (Uppsala University Hospital, University Hospital of Umeå, Linköping University Hospital, Skåne University Hospital, Sahlgrenska University Hospital and Karolinska University Hospital).

The main funder of SCAPIS is the Swedish Heart-Lung Foundation, with considerable support from the Knut and Alice Wallenberg Foundation, Vinnova, The Swedish Research Council and the participating Universities and University Hospitals.

SCAPIS 2

SCAPIS 2, the reexamination of half of the cohort from SCAPIS 1, started in Gothenburg in January 2024 and has now successfully started at all sites. The same study protocol will be used as in the core study, SCAPIS 1. The planned end date of the study is in February 2026 and the ambition from the study is to start sharing data six months after that, i.e. in September 2026.

The exact number of included subjects in SCAPIS 1 and the planned numbers in SCAPIS 2 are as follows:
Gothenburg SCAPIS 1: 6265, SCAPIS 2: 3133, Linköping: 5057, 2529, Malmö: 6251, 3126, Stockholm: 5038, 2519, Umeå: 2507, 1254 and Uppsala: 5036, 2518.

Latest news

SCAPIS Scientific Conference

We are pleased to announce that the next SCAPIS Scientific Conference will take place on March 25, 2026, in Stockholm. We hope you will be able to join us for a day filled with ongoing research, exciting data releases, new results and opportunities. Register here

Register-derived data available

Register-derived data, incident (until 2024) available for application. More information under “Data open for access”.

Pre-access to imaging data from photon-counting CT

This first release will include CT data from the first 100 examinations performed at each SCAPIS 2 site, offering a valuable opportunity for early exploration and review of the data generated by the photon-counting CT. For more information please contact scapis@scapis.org.

Newsletter about the SCAPIS study

Get news from the SCAPIS study. Sign up by registering your email address.

By proceeding, I consent to my personal data being processed in accordance with Hjärt-lungfonden's privacy policy

Logotyp SCAPIS
Logotyp Göteborgs universitet
Logotyp Karolinska institutet
Logotyp Linköpings universitet
Logotyp Lunds universitet
Logotyp Uppsala universitet
Logotyp Umeå universitet
Logotyp Norrlands universitetssjukhus
Logotyp Universitetssjukhuset i Linköping
Logotyp Skånes universitetssjukhus
Logotyp Västra Götalandsregionen
Logotyp Karolinska universitetssjukhuset
Logotyp Akademiska sjukhuset
Logo Swedish Heart-Lung Foundation as main funder of SCAPIS